Initial treatment of severe acute psychosis with fast orally disintegrating risperidone tablets

Pharmacopsychiatry

Volumn 39, Issue 6, 2006, Pages 209-212

  Normann, Claus ^a   Schmauss M ^b   Bakri, N ^c   Gerwe, M ^d   Schreiner, A ^d  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Bezirkskrankenhaus Augsburg ^*  (Germany)

^c Abteilung für Psychiatrie   (Germany)

^d JANSSEN CILAG GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; HALOPERIDOL; LORAZEPAM; NEUROLEPTIC AGENT; PLACEBO; RISPERIDONE; ZUCLOPENTHIXOL;

ADULT; AGED; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EMBOLISM; EXTRAPYRAMIDAL SYNDROME; FEMALE; HUMAN; HYPOTENSION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOSIS; RESPIRATORY DISTRESS; RHINITIS; SCHIZOPHRENIA; SCORING SYSTEM; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANTIPSYCHOTIC AGENTS; CHEMISTRY, PHARMACEUTICAL; ENDPOINT DETERMINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; RISPERIDONE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TABLETS;

EID: 33845419519     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-950498     Document Type: Article

References (14)

1. Allen MH, Currier GW, Carpenter D, Rose RW, Doherty JP. Treatment of behavioral emergencies 2005. J Psychiatr. Pract 2005; 11 (Suppl 1): 5-108
2. Breier A, Meehan K, Birkett M, David S, Ferchland I, Sutton V, Taylor CC, Palmer R, Dossenbach M, Kiesler G, Brook S, Wright P. A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia. Arch Gen Psychiatry 2002; 59: 441-448
3. Brook S, Luvcey JV, Gunn KP. Intramuscular ziprasidone compared with intramuscular haloperidol in the treatment of acute psychosis. Ziprasidone I.M. Study Group. J Clin Psychiatry 2000; 61: 933-941
4. Chue P, Welch R, Binder C. Acceptability and disintegration rates of orally disintegrating risperidone tablets in patients with schizophrenia or schizoaffective disorder. Can J Psychiatry 2004; 49: 701-703
5. Currier GW, Simpson GM. Risperidone liquid concentrate and oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam for treatment of psychotic agitation. J Clin Psychiatry 2001; 62: 153-157
6. Czobor P, Volavka J, Meibach RC. Effect of risperidone on hostility in schizophrenia. J Clin Psychopharmacol 1995; 15: 243-249
7. Hillard JR. Emergency treatment of acute psychosis. J Clin Psychiatry 1998; 59 (Suppl 1): 57-60
8. Hovens JE, Dries PJ, Melamn CT, Wapenaar RJ, Loonen AJ. Oral risperidone with lorazepam versus oral zuclopenthixol with lorazepam in the treatment of acute psychosis in emergency psychiatry: a prospective, comparative, open-label study. J Psychopharmacol 2005; 19: 51-57
9. Kinon BJ, Hill AL, Liu H, Kollack-Walker S. Olanzapine orally disintegrating tablets in the treatment of acutely ill non-compliant patients with schizophrenia. Int J Neuropsychopharmacol 2003; 6: 97-102
10. Lejeune J, Larmo I, Chrzanowski W, Witte R, Karavatos A, Schreiner A, Lex A, Medori R. Oral risperidone plus oral lorazepam versus standard care with intramuscular conventional neuroleptics in the initial phase of treating individuals with acute psychosis. Int Clin Psychopharmacol 2004; 19: 259-269
11. Levy RH. Sedation in acute and chronic agitation. Pharmacotherapy 1996; 16: 152S-159S
12. Raedler TJ, Schreiner A, Naber D, Wiedemann K. Risperidone in the treatment of acute schizophrenia. J Clin Psychopharmacol 2004; 24: 335-338
13. Van Schaick EA, Lechat P, Remmerie BM, Ko G, Lasseter KC, Mannaert E. Pharmacokinetic comparison of fast-disintegrating and conventional tablet formulations of risperidone in healthy volunteers. Clin Ther 2003; 25: 1687-1699
14. Yildiz A, Sachs GS, Turgay A. Pharmacological management of agitation in emergency settings. Emerg Med J 2003; 20: 339-346